A Phase 1 Study of Infusional or Bolus Deflexifol in patients with advanced malignacy after failure of standard treatment
Phase 1
Completed
- Conditions
- Advanced Malignant Cancer
- Registration Number
- ACTRN12618000297224
- Lead Sponsor
- FivePhusion
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method